Anacor Pharmaceuticals Obtains $50,000,000 New Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=947b6ce8-95c9-4853-817f-c487ea91b736&Preview=1 -
Date
1/6/2009 -
Company Name
Anacor Pharmaceuticals -
Mailing Address
1020 East Meadow Circle Palo Alto, CA 94303-4230 -
Company Description
Anacor is developing novel pharmaceuticals for a variety of inflammatory and infectious diseases based on its proprietary, small-molecule, boron-based chemistry. -
Website
http://www.anacor.com -
Transaction Type
Venture Equity -
Transaction Amount
$50,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds from the financing will be used to further develop Anacor’s product pipeline based on its boron chemistry platform. -
M&A Terms
-
Venture Investor
GlaxoSmithKline -
Venture Investor
Rho Ventures -
Venture Investor
Venrock -
Venture Investor
Care Capital -
Venture Investor
Aberdare Ventures -
Venture Investor
Undisclosed
